|
Volumn 18, Issue 3, 2001, Pages 259-262
|
Birth outcome following maternal use of fluoroquinolones
|
Author keywords
Fluoroquinolones; Follow up; Pregnancy; Safety
|
Indexed keywords
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
ARTICLE;
COHORT ANALYSIS;
CONGENITAL MALFORMATION;
DATA BASE;
DENMARK;
DRUG SAFETY;
DRUG USE;
FETOTOXICITY;
FETUS;
FOLLOW UP;
HUMAN;
LOW BIRTH WEIGHT;
PHARMACOEPIDEMIOLOGY;
PREGNANCY;
PREMATURE LABOR;
PRENATAL DRUG EXPOSURE;
PRESCRIPTION;
PREVALENCE;
PRIORITY JOURNAL;
REGISTER;
STATISTICAL ANALYSIS;
TERATOGENICITY;
ABNORMALITIES, DRUG-INDUCED;
ADULT;
COHORT STUDIES;
DENMARK;
FEMALE;
FLUOROQUINOLONES;
HUMANS;
INFANT, LOW BIRTH WEIGHT;
INFANT, NEWBORN;
INFANT, PREMATURE;
OBSTETRIC LABOR, PREMATURE;
PREGNANCY;
PREGNANCY OUTCOME;
PREVALENCE;
REGISTRIES;
|
EID: 0034770705
PISSN: 09248579
EISSN: None
Source Type: Journal
DOI: 10.1016/S0924-8579(01)00390-9 Document Type: Article |
Times cited : (56)
|
References (19)
|